- Home
- SCYX vs XTKG Comparison
SCYX vs XTKG Comparison
Compare SCYX & XTKG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCYX
- XTKG
- Stock Information
- Founded
- SCYX 1999
- XTKG 1997
- Country
- SCYX United States
- XTKG Singapore
- Employees
- SCYX N/A
- XTKG N/A
- Industry
- SCYX Biotechnology: Pharmaceutical Preparations
- XTKG
- Sector
- SCYX Health Care
- XTKG
- Exchange
- SCYX Nasdaq
- XTKG NYSE
- Market Cap
- SCYX 50.3M
- XTKG 53.6M
- IPO Year
- SCYX 2014
- XTKG 2019
- Fundamental
- Price
- SCYX $1.18
- XTKG $2.04
- Analyst Decision
- SCYX Buy
- XTKG
- Analyst Count
- SCYX 1
- XTKG 0
- Target Price
- SCYX N/A
- XTKG N/A
- AVG Volume (30 Days)
- SCYX 165.3K
- XTKG 2.7M
- Earning Date
- SCYX 11-06-2024
- XTKG 11-29-2024
- Dividend Yield
- SCYX N/A
- XTKG N/A
- EPS Growth
- SCYX N/A
- XTKG N/A
- EPS
- SCYX N/A
- XTKG N/A
- Revenue
- SCYX $8,566,000.00
- XTKG $16,824,823.00
- Revenue This Year
- SCYX N/A
- XTKG N/A
- Revenue Next Year
- SCYX $145.59
- XTKG N/A
- P/E Ratio
- SCYX N/A
- XTKG N/A
- Revenue Growth
- SCYX N/A
- XTKG 60.50
- 52 Week Low
- SCYX $1.15
- XTKG $0.08
- 52 Week High
- SCYX $3.07
- XTKG $1.64
- Technical
- Relative Strength Index (RSI)
- SCYX 28.95
- XTKG 39.25
- Support Level
- SCYX $1.25
- XTKG $0.10
- Resistance Level
- SCYX $1.37
- XTKG $0.15
- Average True Range (ATR)
- SCYX 0.06
- XTKG 0.02
- MACD
- SCYX -0.01
- XTKG 0.00
- Stochastic Oscillator
- SCYX 9.26
- XTKG 39.51
About SCYX SCYNEXIS Inc.
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against a broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.
About XTKG X3 HOLDINGS CO LTD
X3 Holdings Co Ltd is company which is responsible for globally providing of Technology Solutions and Services across Diverse Industries that operates across four business segments: digital technologies, renewable energy, Cryptomining Operations, and agriculture technologies.